Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-31 @ 1:55 AM
Study NCT ID:
NCT00685503
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2008-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth
Sponsor:
National Eye Institute (NEI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-05-21
Start Date Type:
None
Primary Completion Date:
2011-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-04-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-24
First Submit QC Date:
None
Study First Post Date:
2008-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-06-30
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL